RE: Updated..........3 Mar 2022 10:01
Apollon Formularies
@apollon_uk
ยท
1h
The Joint Venture will be mutually beneficial, with Tri-Medi Canna gaining access to Apollon's vast experience across the value chain, from skill transfers in extraction and processing, pharmaceutical level drug development, clinical trials, patient treatment centres
https://twitter.com/apollon_uk